Home » GENENTECH ACQUIRES THE ORIGENE TRUECLONECOLLECTION
GENENTECH ACQUIRES THE ORIGENE TRUECLONECOLLECTION
OriGene Technologies Inc. announced that Genentech has purchased their TrueClone Collection of full-length human cDNAs suitable for transfection and direct in vitro expression. Although there are many different efforts to collect every human full-length cDNA
clones, OriGene's Trueclone Collection is the most comprehensive to date. OriGene
cDNA clones are expression-ready, authentic full-length cDNA plasmids for use
in target and lead identification and validation.
Finanzen.net
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May